Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy
Author:
Publisher
Wiley
Subject
Ophthalmology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2011.02184.x/fullpdf
Reference37 articles.
1. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy;Adamis;Am J Ophthalmol,1994
2. Inhibition of vascular endothelial growth factor prevents retinal ischemia associated iris neovascularization in a nonhuman primate;Adamis;Arch Ophthalmol,1996
3. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals;Adamis;Ophthalmology,2006
4. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N Engl J Med,1994
5. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins;Aiello;Proc Natl Acad Sci USA,1995
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Laser Treatment for Diabetic Retinopathy: History, Mechanism, and Novel Technologies;Journal of Clinical Medicine;2024-09-13
2. Anti-vascular endothelial growth factor injections vs panretinal photocoagulation laser therapy for proliferative diabetic retinopathy – A systematic review and meta-analysis;Ophthalmology Retina;2024-08
3. Extracellular Vesicles and Diabetic Retinopathy: Nano-sized Vesicles With Mega-sized Hopes;Diabetic Retinopathy - Advancement in Understanding the Pathophysiology and Management Strategies [Working Title];2024-06-24
4. Loss to Follow up in Patients with Proliferative Diabetic Retinopathy Treated with Anti-VEGF Therapy and/or Panretinal Photocoagulation in the United States;Ophthalmology Retina;2024-04
5. Regression of Neovascularization after Panretinal Photocoagulation Combined with Anti-VEGF Injection for Proliferative Diabetic Retinopathy—A Review;Diagnostics;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3